Pleurocidin vs omega-conotoxin MVIIA

Head-to-head comparison of Pleurocidin (Pleurocidin (winter flounder antimicrobial peptide)) and omega-conotoxin MVIIA (Ziconotide) — benefits, dosing, side effects, research data, and where to buy.

PropertyPleurocidinomega-conotoxin MVIIA
CategoryMarine-DerivedMarine-Derived
Full NamePleurocidin (winter flounder antimicrobial peptide)Ziconotide
Molecular Weight~2.8 kDa2639 Da
Half-LifeNR4.5 h (CSF)
Amino Acids2525
Typical DoseNR1.2 mcg/day initial, titrate as tolerated
Routein vitro|topical preclinicalintrathecal
Purity≥98%≥98%
Studies Count8278
Research StatusPre-clinicalApproved

Pleurocidin Benefits

  • antimicrobial
  • anticancer lead
  • endotoxin neutralization

omega-conotoxin MVIIA Benefits

  • analgesic
  • ion-channel blocker
  • neuroactive

Pleurocidin Dosing

NR|NR

omega-conotoxin MVIIA Dosing

chronic refractory pain|CaV2.2

Pleurocidin Side Effects

  • membrane toxicity
  • hemolysis at high concentrations
  • protease sensitivity

omega-conotoxin MVIIA Side Effects

  • Conus magus

Research Overview

Pleurocidin

Preclinical studies report membrane-active killing of bacteria and some activity against cancer cell lines. Multiple analogs have been developed to reduce toxicity while preserving potency.

omega-conotoxin MVIIA

Foundational marine peptide drug; approved as ziconotide for intrathecal treatment of severe chronic pain when other therapies fail.

Ready to buy?

Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.

Common Stacking Partners

Pleurocidin stacks with:

Pleurocidin

omega-conotoxin MVIIA stacks with:

Conus magusomega-conotoxinpain
marine-derivedantimicrobial peptidebioactive peptidebioactivecone snailpeptide drug